Perceptive Advisors’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,757,160
| Closed | -$38M | – | 113 |
|
|
2022
Q4 | $38M | Sell |
1,757,160
-602,979
| -26% | -$12.7M | 1.07% | 27 |
|
|
2022
Q3 | $45.7M | Hold |
2,360,139
| – | – | 1.33% | 23 |
|
|
2022
Q2 | $46.9M | Hold |
2,360,139
| – | – | 1.47% | 16 |
|
|
2022
Q1 | $70.4M | Hold |
2,360,139
| – | – | 1.41% | 20 |
|
|
2021
Q4 | $55M | Hold |
2,360,139
| – | – | 0.85% | 31 |
|
|
2021
Q3 | $73.6M | Hold |
2,360,139
| – | – | 1.07% | 26 |
|
|
2021
Q2 | $83M | Hold |
2,360,139
| – | – | 1.08% | 25 |
|
|
2021
Q1 | $83.2M | Hold |
2,360,139
| – | – | 1.05% | 25 |
|
|
2020
Q4 | $88.5M | Hold |
2,360,139
| – | – | 0.95% | 29 |
|
|
2020
Q3 | $78.8M | Buy |
2,360,139
+400,000
| +20% | +$11.7M | 1.15% | 22 |
|
|
2020
Q2 | $51.9M | Hold |
1,960,139
| – | – | 0.84% | 30 |
|
|
2020
Q1 | $31.9M | Buy |
1,960,139
+255,809
| +15% | +$5.62M | 0.83% | 28 |
|
|
2019
Q4 | $43.3M | Hold |
1,704,330
| – | – | 0.86% | 28 |
|
|
2019
Q3 | $34.1M | Hold |
1,704,330
| – | – | 0.92% | 29 |
|
|
2019
Q2 | $54.9M | Hold |
1,704,330
| – | – | 1.26% | 18 |
|
|
2019
Q1 | $54.9M | Hold |
1,704,330
| – | – | 1.55% | 20 |
|
|
2018
Q4 | $39.5M | Hold |
1,704,330
| – | – | 1.5% | 22 |
|
|
2018
Q3 | $56.2M | Hold |
1,704,330
| – | – | 1.5% | 22 |
|
|
2018
Q2 | $60.5M | Hold |
1,704,330
| – | – | 1.59% | 16 |
|
|
2018
Q1 | $55.5M | Buy |
1,704,330
+384,330
| +29% | +$12.9M | 1.55% | 19 |
|
|
2017
Q4 | $33.8M | Buy |
1,320,000
+475,000
| +56% | +$12M | 1.12% | 22 |
|
|
2017
Q3 | $17.7M | Hold |
845,000
| – | – | 0.68% | 35 |
|
|
2017
Q2 | $17.4M | Buy |
+845,000
| New | +$17.3M | 0.88% | 33 |
|
Other funds holding ALBO
Perceptive Advisors's ALBO Position: Q1 2023 in Review
Perceptive Advisors sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 1,757,160 shares — an estimated $38M sold.
Perceptive Advisors first reported a position in ALBO in Q2 2017 and held it in 23 quarters. The position peaked at $88.5M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Perceptive Advisors reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Perceptive Advisors sold 1,757,160 Albireo Pharma Inc shares in Q1 2023, an estimated $38M.
- Perceptive Advisors first reported a position in Albireo Pharma Inc in Q2 2017 and held it in 23 quarters.
- Perceptive Advisors's Albireo Pharma Inc position peaked at $88.5M in Q4 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.